Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

The 2025 Chinese guideline on shingles-related pain treats the acute phase and chronic nerve pain as one continuous condition, with antivirals inside 72 hours, early nerve blocks, and vaccination as the real prevention.

What this guide covers: Why the pain is the problem · Presentation · Assessment · Acute treatment · Preventing the chronic phase

Shingles is the reactivation of the varicella-zoster virus that has been dormant in a sensory nerve ganglion since childhood chickenpox. The rash heals in most people, but the pain can outlast it by months or years — postherpetic neuralgia, or PHN — and that chronic pain is what the 2025 Chinese guideline for full-cycle management of shingles-related pain is designed to prevent.

Why the pain is the problem

The risk rises steeply with age. Incidence climbs sharply after 50 and continues upward; in Chinese multicentre data the rate of PHN is about 8 percent in people aged 40 to 49, around 21 percent in the 50 to 59 group, and about 35 percent above 60. Immunocompromised patients are at substantially higher risk.

The biology explains the urgency. During the acute phase the virus replicates along the sensory nerve, producing inflammation, axonal injury and demyelination. If the pain signalling persists, the spinal cord undergoes central sensitisation — the pain threshold falls and stays down. Once that has happened, treating the skin no longer helps, because the problem has moved into the nervous system.

Presentation

Classic shingles is a unilateral, dermatomal burning or stabbing pain, often appearing two to five days before any rash, followed by the characteristic vesicular eruption. Involvement of the ophthalmic division of the trigeminal nerve needs ophthalmology input because of the risk of keratitis and uveitis. Ramsay Hunt syndrome affects the ear and may cause facial weakness and hearing loss. Motor involvement occasionally causes focal muscle weakness.

Assessment

Pain intensity is scored with the numeric rating scale. Neuropathic character is screened with tools such as DN4 or the painDETECT questionnaire. Quality of life measures such as SF-36 are recommended, because PHN affects sleep, mood and function far beyond the pain score.

Acute treatment

Antiviral therapy should start within 72 hours of rash onset. The guideline notes that famciclovir regimens can shorten the duration of pain substantially, and that aciclovir and valaciclovir are alternatives. In older patients a 10-day course is often used rather than 7 days.

Pain management begins at the same time, not after the rash clears. Calcium channel ligands such as pregabalin or gabapentin are used for the neuropathic component; gabapentin requires titration over weeks to reach an effective dose. Non-steroidal anti-inflammatory drugs help the inflammatory component but should be used for a limited period. A short tapering course of corticosteroids is an option for selected older patients without contraindications.

Preventing the chronic phase

The interventional section is the distinctive part of this guideline. Nerve blocks — including paravertebral blocks — performed early in the course are associated with a marked reduction in later PHN. Pulsed radiofrequency and spinal cord stimulation have defined windows, with stimulation most effective when applied some weeks after onset in patients who are already developing chronic pain.

Established postherpetic neuralgia

First-line drugs remain gabapentinoids and tricyclic antidepressants, with topical lidocaine or capsaicin useful when a small area is involved and systemic side effects limit dosing. Dosing must be adjusted for renal function. Tramadol or stronger opioids are reserved for carefully selected patients and for short periods.

Special situations

Aciclovir is used in pregnancy when needed; brivudine and valproate are contraindicated. Paracetamol is the preferred analgesic in pregnancy, with a daily ceiling.

Prevention

Vaccination is the central preventive measure. The recombinant subunit vaccine offers very high protection in adults over 50 and is preferred for immunocompromised patients because it is not a live vaccine. The live attenuated vaccine is an alternative for some age groups but protection wanes over several years.

Practical takeaway

Two things determine the outcome more than anything else: getting antivirals started within 72 hours, and getting pain treated early rather than waiting to see whether it settles.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.